Author Type

Graduate Student

Date of Award

1984

Document Type

Thesis

Publication Status

Version of Record

Submission Date

October 2026

Abstract

Five commercially available (OTC) and one non-commercially available contraceptive-germicidal agents were tested in vitro for their potential growth inhibition properties against Ureaplasma urealyticum, a human genital Mycoplasma. These organisms are capable of causing numerous genitourinary disorders including vulvovaginitis, cervicitis, endometritis, and nongonococcal urethritis (NGU). Exposure of the test microorganisms to the OTC intravaginal chemical contraceptives, following 24-hour incubation intervals, and ·a continuous incubation regimen for two weeks, indicated that a static influence was evident with only one dilution factor being Ureaplasma-cidal. After slight procedure modification for testing the SGCA noncommercially available product, because the growth medium components were reacting with the SGCA preparation, a marked difference in effectiveness was found. Unlike OTC contraceptives, the liquid concentrate form of SGCA was shown to be Ureaplasma-cidal at each dilution and never Ureaplasma-static.

Extent

63 p.

Comments

FAU Electronic Theses and Dissertations Collection|Thesis (M.S.)--Florida Atlantic University, 1984.|Charles E. Schmidt College of Science|FAU Electronic Theses and Dissertations Collection

Identifier

FADT14196

Format

pdf

Download

Share

COinS